RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$69.65
Tradestie Score
63
Market Cap
$6.00B
Revenue Growth
0.3%
Analyst Upside
+35.9%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRL
Charles River Laboratories International, Inc.
|
$315.45
|
$8.39B | - | 44 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$162.59
|
$7.81B | - | 59 | Compare |
|
BLLN
BLLN
|
$103.50
|
$4.77B | 160.4 | 57 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.93
|
$4.60B | 30.9 | 62 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$100.39
|
$3.51B | 24.2 | 52 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$68.74
|
$3.26B | - | 71 | Compare |
|
VCYT
Veracyte, Inc.
|
$44.79
|
$2.85B | 31.3 | 51 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$15.49
|
$2.72B | - | 37 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$124.67
|
$2.24B | - | 45 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.42
|
$2.22B | - | 63 | Compare |
More RDNT Analysis
Data updated: Oct 20, 2026 | Industry: Diagnostics & Research (SIC 8071)
38 stocks in this industry